Carbon nanotubes detect lung malignancy markers in the breath Using a range of nanotube devices, each covered with a different organic material, researchers in the Israel Institute of Technology are suffering from diagnostic system that may be in a position to diagnose lung cancer simply by sampling a patient’s breath. The outcomes of this study, which was led by Hossam Haick, Ph.D same same ., come in the journal Nano Letters. Dr. Haick and his collaborators first created individual devices consisting of random networks of single-walled carbon nanotubes coated with 1 of 10 different insulating nonpolymeric organic components.
Caraco Pharmaceutical Labs responds to FDA warning Caraco Pharmaceutical Laboratories, Ltd. Announced today that it provides timely submitted its response to the FDA caution letter that was received on October 31, 2008. In the warning letter, the FDA requested a reply from Caraco within 15 business days, november 24 ending, 2008. As disclosed previously, the warning letter was issued as a follow-up to the last FDA inspection of the Company’s manufacturing unit in Detroit, Michigan that was initiated in May 2008. Until the Company’s responses to the observations have already been clarified and explanations offered to the fulfillment of the FDA, the FDA may in the near term withhold approval of pending new drug applications listing the service as the manufacturer.